192
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis

, , , , , , , , & show all
Pages 358-361 | Received 30 Apr 2015, Accepted 09 Aug 2015, Published online: 07 Oct 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tomohiro Kubota, Syuji Takei, Masaki Shimizu, Junko Yasumura, Yasuo Nakagishi, Toshitaka Kizawa, Masato Yashiro, Hiroyuki Wakiguchi, Yuichi Yamasaki & Yoshifumi Kawano. (2018) Early prediction for over two years efficacy of the first biologic agent for polyarticular juvenile idiopathic arthritis: A multi-institutional study in Japan. Modern Rheumatology 28:5, pages 826-831.
Read now

Articles from other publishers (2)

Lily Siok Hoon Lim, Armend Lokku, Eleanor Pullenayegum & Sarah Ringold. (2023) Probability of Response in the First Sixteen Weeks After Starting Biologics: An Analysis of Juvenile Idiopathic Arthritis Biologics Trials. Arthritis Care & Research 75:6, pages 1238-1249.
Crossref
Şerife Gül Karadağ, Fatma Gül Demirkan, Rahime Koç, Figen Çakmak, Hafize Emine Sönmez & Nuray Aktay Ayaz. (2021) Approach to switching biologics in juvenile idiopathic arthritis: a real-life experience. Rheumatology International 42:1, pages 141-147.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.